Table I.
Materials used as tumor markers.
A, Viral vectors | ||
---|---|---|
| ||
Examples | Advantages | Disadvantages |
• Adenovirus | • High transfection efficiency | • Generation of immune response |
• Adeno-associated virus | • Efficient in initiating gene expression | • Toxicity |
• HSV-1 | • Possibility of proto-oncogene activation | |
• HSV amplicon | • Specific targeting | |
• Sindbis | ||
• Poliovirus replicon | • High production cost | |
• Lentivirus/MoMLV | ||
• Limitations in deliverable gene size | ||
| ||
B, Non-viral vectors | ||
| ||
Therapeutic DNA, RNAsa and ODNs |
|
|
Anaerobic bacteria |
|
|
Including microRNAs, short hairpin RNAs and small interfering RNAs.
HSV, herpes simplex virus; MoMLV, Moloney murine leukemia virus; ODNs, oligodeoxynucleotides.